|
Market Closed -
Xetra
11:35:57 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 51.22 EUR | +2.28% |
|
+5.00% | +598.77% |
| Market Cap | 9.9B 8.55B 8.05B 7.31B 13.76B 949B 13.96B 94.4B 36.99B 475B 37.18B 36.37B 1,581B | P/E 2026 * |
-16.4x | P/E 2027 * | -31.5x |
|---|---|---|---|---|---|
| Enterprise Value | 9.8B 8.46B 7.96B 7.24B 13.61B 939B 13.81B 93.42B 36.61B 470B 36.79B 36B 1,564B | EV / Sales 2026 * |
10.7x | EV / Sales 2027 * | 7.1x |
| Free-Float |
99.05% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ionis Pharmaceuticals, Inc.
| 1 day | +2.28% | ||
| 1 week | +5.00% | ||
| Current month | +14.20% | ||
| 1 month | +8.31% | ||
| 3 months | +598.77% | ||
| 6 months | +598.77% | ||
| Current year | +598.77% |
| 1 week | 48.33 |  | 51.22 |
| 1 month | 43.86 | | 51.22 |
| Current year | 43.86 | | 75.2 |
| 1 year | 43.86 | | 75.2 |
| 3 years | 43.86 | | 75.2 |
| 5 years | 43.86 | | 75.2 |
| 10 years | 43.86 | | 75.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
D. Walke
IRC | Investor Relations Contact | 60 | 2012-06-30 |
Brett Monia
CEO | Chief Executive Officer | 64 | 2019-12-31 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 64 | 2000-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Klein
BRD | Director/Board Member | 64 | 2005-12-12 |
| Director/Board Member | 73 | 2002-04-30 | |
Brett Monia
BRD | Director/Board Member | 64 | 2019-03-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.28% | +5.00% | - | - | 9.74B | |
| -0.11% | -1.67% | +1.80% | +19.90% | 48.84B | |
| +1.89% | +5.08% | +492.59% | +629.24% | 45.44B | |
| +1.83% | +2.75% | +15.61% | +91.22% | 41.22B | |
| -0.50% | -1.56% | +24.67% | +12.17% | 39.71B | |
| -2.74% | -7.13% | +18.72% | +49.04% | 32.6B | |
| -1.14% | -2.51% | +27.52% | +136.42% | 16.67B | |
| +0.59% | -2.25% | - | - | 16.25B | |
| -0.49% | -0.34% | +3.45% | +29.14% | 14.08B | |
| -2.60% | -1.00% | +77.85% | +40.37% | 13.68B | |
| Average | -0.10% | -0.89% | +82.78% | +125.94% | 29.83B | |
| Weighted average by Cap. | +0.06% | -0.41% | +104.17% | +153.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 913M 789M 742M 675M 1.27B 87.52B 1.29B 8.71B 3.41B 43.77B 3.43B 3.35B 146B | 1.4B 1.21B 1.14B 1.04B 1.95B 134B 1.98B 13.37B 5.24B 67.19B 5.26B 5.15B 224B |
| Net income | -602M -520M -490M -445M -837M -57.72B -849M -5.74B -2.25B -28.87B -2.26B -2.21B -96.16B | -326M -281M -265M -241M -453M -31.22B -459M -3.11B -1.22B -15.62B -1.22B -1.2B -52.01B |
| Net Debt | -103M -88.93M -83.67M -76.05M -143M -9.87B -145M -981M -385M -4.93B -387M -378M -16.43B | 57.45M 49.62M 46.69M 42.43M 79.81M 5.5B 80.98M 548M 215M 2.75B 216M 211M 9.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-18 | €51.22 | +2.28% | 0 |
| 26-08-17 | €50.08 | +3.62% | 0 |
| 26-08-14 | €48.33 | -0.49% | 20 |
| 26-08-13 | €48.57 | -1.04% | 60 |
| 26-08-12 | €49.08 | +0.62% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IONS Stock
- ISI Stock
Select your edition
All financial news and data tailored to specific country editions
